age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
49.91599
|
male
| 1
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 26
| 220,490
| 101,904.875
| null | 36
|
black
| 26.796875
| 25
| 0.515991
| 0.399963
| 19
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 5
| 115
| 15
| 55
| 14
| 36.09375
| 136.65625
| 2
| 1
| 0.599976
| 136
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 3.306152
| 20
| 1
|
51.56699
|
female
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 1,435,423
| 3,877.0879
| null | 11
|
other
| 35.296875
| 63
| 0.530884
| 0.33197
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 58
| 10.5
| 72
| 24
| 36
| null | 2.199707
| 19.796875
| 2.099609
| 126
| null | null | null | null | null | null | null | 2.439941
| 1,607
| 0
|
55.13998
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 7,322
| 3,337.082
| null | 10
|
white
| 15.298828
| 25
| 0.931885
| 0.883911
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 4
| 71
| 7.599609
| 84
| 20
| 36.79688
| 223.78125
| null | null | 0.699951
| 136
| 7.439453
| null | null | null | 1
| 5
|
adl>=4 (>=5 if sur)
| 5
| 1,604
| 0
|
30.69099
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 44
| 138,003
| 66,716.625
| null | 26
|
white
| 25.597656
| 33
| 0.733887
| 0.650879
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 19
| 110
| 17.199219
| 150
| 45
| 38.69531
| 357.5
| null | null | 0.599976
| 135
| 7.479492
| null | null | null | null | null | null | 2.57959
| 673
| 1
|
47.34799
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 37
| 23,807
| 11,111.2266
| null | 24
|
white
| 22.796875
| 26
| 0.790894
| 0.7229
| 1
| 0
| 0
|
no
| 0.98
| 0.9
|
no dnr
| 6
| 77
| 14.298828
| 100
| 45
| 38.09375
| 196.65625
| null | 0.599976
| 0.599976
| 143
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 3.479492
| 19
| 1
|
60.23297
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 16,410
| 9,693.4141
| null | 11
|
other
| 18.296875
| 56
| 0.69397
| 0.403992
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 79
| 19.898438
| 160
| 16
| 36.39844
| 228.5625
| 4.199219
| 1.299805
| 1.799805
| 134
| 7.459961
| null | null | null | null | null |
<2 mo. follow-up
| 3.338867
| 17
| 1
|
37.08099
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 7,547
| 4,304.6484
| null | 6.5
|
white
| 24.097656
| 24
| 0.8479
| 0.75
| 1
| 0
| 0
|
no
| 0.95
| 0.5
|
no dnr
| 7
| 105
| 7.599609
| 100
| 22
| 38.79688
| null | null | 6.899414
| 0.599976
| 133
| null | null | null | null | null | null | null | 3.242188
| 1,601
| 0
|
63.25
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 13
|
$25-$50k
| 0
| 15,400
| 7,650.8516
| null | 11
|
asian
| 5.699219
| 21
| 0.872925
| 0.713989
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 87
| 11.199219
| 100
| 30
| 38
| null | 4.599609
| 0.5
| 0.899902
| 134
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.87085
| 1,599
| 0
|
51.87698
|
male
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 22,975
| 10,616.9688
| null | 13
|
white
| 23.699219
| 14
| 0.591919
| 0.272949
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 91
| 3.899902
| 100
| 20
| 36.59375
| 285.6875
| 2.899902
| 0.299988
| 0.899902
| 133
| 7.519531
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 202
| 1
|
69.50299
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 45,162
| 22,656.4219
| null | 18.5
|
white
| 30.699219
| 43
| 0.62793
| 0.44397
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 13
| 53
| 14.599609
| 110
| 20
| 36.89844
| 306
| null | null | 1.699951
| 127
| 7.269531
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 25
| 1
|
84.43799
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 25,793
| 11,553.2656
| null | 17.5
|
white
| 16.699219
| 35
| 0.799927
| 0.677979
| 1
| 0
| 0
|
yes
| 0.8
| 0.2
|
no dnr
| 8
| 60
| 4.199219
| 85
| 38
| 37.5
| 246.9375
| null | 0.299988
| 1
| 131
| 7.589844
| null | null | null | null | null |
<2 mo. follow-up
| 3.622559
| 31
| 1
|
46.60397
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 17,707
| 9,833.4844
| null | 9
|
white
| 19.097656
| 19
| 0.708984
| 0.426941
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 60
| 7.699219
| 134
| 22
| 38.79688
| null | null | null | 0.899902
| 135
| null | null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 593
| 1
|
60.07397
|
female
| 1
| 4
|
Lung Cancer
|
Cancer
| 1
| null | null | 41
| 6,149
| 2,807.7559
| null | 11
|
white
| 31.5
| 22
| 0.146973
| 0.008999
| 1
| 0
| 0
|
metastatic
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 107
| 10.898438
| 116
| 24
| 36
| 228
| 2.899902
| null | 0.399963
| 144
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 3.416992
| 4
| 1
|
62.27197
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 16
| null | 0
| 150,556
| 75,833.1875
| null | 38.5
|
white
| 32.195313
| 70
| 0.584961
| 0.475952
| 12
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 68
| 6.799805
| 140
| 36
| 38
| 369.5625
| 3.399902
| 6.099609
| 7.299805
| 132
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
48.353
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 100
| 565,876
| 341,404.25
| null | 59
|
white
| 75.1875
| 97
| 0
| 0
| 54
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 20
| 49.898438
| 135
| 24
| 36.29688
| 76
| 4.399414
| 24.097656
| 3.399902
| 149
| 7.239258
| null | null | null | null | null |
<2 mo. follow-up
| 2.887695
| 3
| 1
|
78.33795
|
male
| 1
| 4
|
Coma
|
Coma
| 0
| null | null | 100
| 31,356
| 14,755.6641
| null | 39
|
white
| 38.09375
| 65
| 0.001
| 0
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 50
| 6.599609
| 150
| 22
| 37.5
| 143.3125
| null | null | 2.099609
| 128
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.251465
| 4
| 1
|
58.14099
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 4,642
| 2,539.3711
| null | 5
|
white
| 17.398438
| 19
| 0.900879
| 0.833984
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 117
| 9.099609
| 105
| 24
| 36.5
| 252.375
| null | null | 0.899902
| 140
| 7.289062
| null | null | null | null | null | null | 2.500488
| 1,241
| 1
|
60.87299
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 29,509
| 15,321.5625
| null | 23.5
|
black
| 17.898438
| 20
| 0.891968
| 0.819946
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 11
| 67
| 9.798828
| 75
| 20
| 36.29688
| null | null | 1.399902
| 1.199951
| 131
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.648926
| 449
| 1
|
51.62198
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
| null | 44
| 85,043
| 42,495
| null | 47
|
black
| 44.398438
| 111
| 0.009998
| 0.002
| 17
| 0
| 0
|
yes
| null | null |
no dnr
| 4
| 57
| 0.049995
| 145
| 40
| 40
| 178
| null | 2.199707
| 7.799805
| 133
| 7.289062
| null | null | null | null | null |
<2 mo. follow-up
| 2.771484
| 4
| 1
|
48.62399
|
female
| 0
| 42
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 0
| 95,852
| null | null | 14.75
|
white
| 20.5
| 42
| 0.72998
| 0.645996
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 26
| 62
| 8.099609
| 110
| 20
| 37.5
| null | 2.399902
| 2
| 2.099609
| 141
| null | null | null | null | null | 6
| null | 6
| 138
| 1
|
29.63699
|
male
| 0
| 20
|
Coma
|
Coma
| 1
| 12
| null | 94
| 168,489
| null | null | 24.333328
|
hispanic
| 22.796875
| 20
| 0.458984
| 0.385986
| 7
| 0
| 0
|
yes
| 0.4
| 0.3
|
no dnr
| 20
| 67
| 17.398438
| 40
| 14
| 35.89844
| 230
| null | null | 0.899902
| 135
| 7.509766
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 30
| 1
|
54.146
|
male
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 44,109
| 24,268.8281
| null | 17
|
white
| 7
| 22
| 0.922974
| 0.820923
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.75
|
no dnr
| 11
| 117
| 18.398438
| 90
| 14
| 37
| null | 5.099609
| 3
| 1
| 133
| null | null | null | null | null | null | null | 2.172363
| 824
| 1
|
68.16998
|
female
| 0
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 38,996
| 19,592.3438
| null | 13.5
|
white
| 22.097656
| 33
| 0.700928
| 0.537964
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 11
| 97
| 19.398438
| 110
| 22
| 37
| 282.8125
| 1.899902
| 3.399902
| 0.799927
| 137
| 7.339844
| null | null | null | null | null | null | 3.621582
| 1,591
| 0
|
47.73398
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 15
|
under $11k
| 0
| 30,953
| null | null | 14.5
|
black
| 33.09375
| 32
| 0.744995
| 0.598999
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 10
| 43
| 5.299805
| 90
| 22
| 36
| null | 3.699707
| 3.099609
| 1.199951
| 126
| null | null | null | null | 6
| null |
no(M2 and SIP pres)
| 4.527397
| 806
| 1
|
91.84399
|
female
| 1
| 4
|
Coma
|
Coma
| 0
| null | null | 100
| 11,415
| 5,410.4688
| null | 7
|
white
| 26.097656
| 49
| 0.017998
| 0.007
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 73
| 28.296875
| 100
| 36
| 35.29688
| 332
| 2.899902
| 0.5
| 1.699951
| 143
| 7.549805
| null | null | null | null | null |
<2 mo. follow-up
| 4.032227
| 4
| 1
|
59.39798
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 8,512
| 4,250.8945
| null | 14
|
white
| 15.298828
| 11
| 0.846924
| 0.662964
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.4
|
no dnr
| 6
| 71
| 6.099609
| 60
| 22
| 37.79688
| null | 3.399902
| null | 0.899902
| 139
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 134
| 1
|
49.59598
|
female
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 102,876
| null | null | 43.5
| null | 52.796875
| 85
| 0.168976
| 0.084991
| 2
| 0
| 0
|
no
| null | null |
dnr after sadm
| 9
| 50
| 15.199219
| 170
| 24
| 39.29688
| 65.32812
| 4.199219
| 24.199219
| 7.099609
| 143
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 2.527832
| 9
| 1
|
51.086
|
female
| 0
| 69
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
$25-$50k
| 26
| 480,519
| null | null | 37.5
|
hispanic
| 30.898438
| 51
| 0.599976
| 0.492981
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 69
| 110
| 18.699219
| 130
| 20
| 39.19531
| 270
| 3.199707
| 11.5
| 1.5
| 150
| 7.519531
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,585
| 0
|
46.22598
|
male
| 0
| 46
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 349,052
| null | null | 30
|
hispanic
| 31.199219
| 33
| 0.783936
| 0.653931
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 46
| 61
| 13.5
| 145
| 8
| 38.39844
| 155.09375
| 2.899902
| 1.399902
| 1
| 129
| 7.5
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,585
| 0
|
76.77197
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 92,775
| null | null | 23
|
white
| 22
| 36
| 0.755981
| 0.678955
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 19
| 70
| 18.097656
| 60
| 20
| 38.79688
| 151.65625
| 2.299805
| null | 1.099854
| 133
| 7.5
| null | null | null | null | null | null | 2.277344
| 1,584
| 0
|
50.59497
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 100
| 93,265
| 49,813.9688
| null | 42
|
hispanic
| 53.296875
| 118
| 0
| 0
| 31
| 1
| 0
|
no
| null | null |
no dnr
| 5
| 37
| 17.699219
| 75
| 40
| 36.89844
| 143
| 1.5
| 21
| 3
| 134
| 7.079102
| null | null | null | null | null |
<2 mo. follow-up
| 4.154297
| 5
| 1
|
60.56897
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 26
| 75,752
| 36,327.7812
| null | 15
|
white
| 17.5
| 17
| 0.819946
| 0.758911
| 4
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 13
| 60
| 13.099609
| 72
| 10
| 38.39844
| 205.4375
| null | null | 0.699951
| 135
| 7.449219
| null | null | null | null | null | null | 3.694824
| 1,584
| 0
|
43.21399
|
female
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 26
| 43,810
| 18,669.25
| null | 26
| null | 30.5
| 59
| 0.428955
| 0.30896
| 2
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 6
| 57
| 7.699219
| 120
| 36
| 39.19531
| 150
| null | null | 1.899902
| 134
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 2.734863
| 6
| 1
|
82.63098
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 7,920
| 4,590.6367
| null | 15
|
white
| 23
| 35
| 0.754883
| 0.612915
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 77
| 19.398438
| 70
| 22
| 36.39844
| null | null | null | 2.299805
| 132
| null | null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 30
| 1
|
80.23798
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 44
| 43,960
| 22,739.5156
| null | 25
|
white
| 21.5
| 21
| 0.643921
| 0.542969
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 9
| 113
| 15
| 60
| 10
| 37.89844
| 142.5
| null | null | 1.099854
| 136
| 7.459961
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 258
| 1
|
26.023
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
|
under $11k
| 44
| 166,772
| 82,111.625
| null | 47
|
hispanic
| 52.796875
| 62
| 0.026997
| 0.007
| 28
| 0
| 0
|
yes
| 0.3
| 0.2
|
dnr after sadm
| 6
| 40
| 3.299805
| 125
| 32
| 36
| 158
| null | null | 2.899902
| 130
| 7.319336
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
22.72699
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
>$50k
| 0
| 23,778
| 10,942.8516
| null | 12
|
black
| 26.398438
| 28
| 0.876953
| 0.833984
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 99
| 6.799805
| 112
| 40
| 38.5
| 140.8125
| null | null | 0.799927
| 134
| 7.469727
| null | null | null | 2
| 0
| null | 0
| 1,579
| 0
|
52.67599
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 17
|
>$50k
| 0
| 22,661
| 12,761.7266
| null | 14.5
|
white
| 20.398438
| 16
| 0.666992
| 0.366943
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.7
|
no dnr
| 9
| 104
| 37.296875
| 78
| 16
| 37.79688
| null | null | null | 0.899902
| 128
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 544
| 1
|
64.11798
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 3
| null | null | 0
| 12,023
| 5,635.4844
| null | 8
|
black
| 4
| 26
| 0.887939
| 0.745972
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 8
| 109
| 10.5
| 78
| 16
| 36.39844
| null | 4.699219
| 0.699951
| 1.299805
| 134
| null | null | null | null | null | null | null | 2.819336
| 183
| 1
|
36.211
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 44
| 374,053
| 180,218.625
| null | 44.666657
|
black
| 40.09375
| 65
| 0.208984
| 0.113998
| 31
| 0
| 0
|
yes
| 0.5
| 0.125
|
no dnr
| 17
| 130
| 7.399414
| 125
| 14
| 37.5
| 87.5
| 3.299805
| 18.597656
| 2.5
| 142
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 3.503418
| 17
| 1
|
29.588
|
male
| 0
| 93
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$11-$25k
| 41
| 563,075
| null | null | 37.25
|
black
| 38.5
| 54
| 0.485962
| 0.367981
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 93
| 115
| 1.899902
| 120
| 38
| 35.79688
| 305
| null | 3.399902
| 5.599609
| 137
| 7.389648
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.710449
| 1,578
| 0
|
63.95599
|
male
| 1
| 21
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
>$50k
| 0
| 68,631
| null | null | 20
|
hispanic
| 26.699219
| 35
| 0.777954
| 0.645996
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 19
| 68
| 8.099609
| 100
| 16
| 36
| null | null | 2.199707
| 1.599854
| 125
| null | null | null | null | 5
| null |
<2 mo. follow-up
| 3.855299
| 21
| 1
|
70.90997
|
male
| 1
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 18
| null | 0
| 13,400
| 7,033.3555
| null | 9
|
white
| 14.599609
| 35
| 0.896973
| 0.826904
| 1
| 1
| 1
|
no
| null | null |
no dnr
| 8
| 93
| 10.099609
| 72
| 20
| 36
| null | 4.699219
| null | 2.5
| 138
| null | null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 8
| 1
|
66.63098
|
female
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 10
|
>$50k
| 0
| 14,175
| 7,477.4492
| null | 18.5
|
white
| 24.199219
| 33
| 0.599976
| 0.409973
| 1
| 0
| 0
|
yes
| 0.85
| 0.6
|
no dnr
| 10
| 80
| 5.699219
| 110
| 22
| 36
| null | 3
| 2.599609
| 2
| 140
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.280762
| 229
| 1
|
77.17499
|
female
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 14,976
| 7,870.4492
| null | 7
|
white
| 20.597656
| 25
| 0.638916
| 0.458984
| 2
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 9
| 82
| 7.799805
| 72
| 20
| 36
| null | null | 6.299805
| 1.199951
| 138
| null | null | null | null | null | null | null | 3.434082
| 183
| 1
|
60.54498
|
male
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 26
| 283,844
| 136,717.875
| null | 41
|
hispanic
| 29.097656
| 71
| 0.550903
| 0.437988
| 16
| 1
| 0
|
no
| 0.75
| 0.75
|
dnr after sadm
| 14
| 107
| 10.599609
| 125
| 35
| 38.5
| 202
| 1.699951
| 9.298828
| 1.199951
| 143
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.759277
| 16
| 1
|
76.56696
|
male
| 1
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 26
| 308,455
| null | null | 40.25
|
white
| 28.699219
| 66
| 0.376953
| 0.258972
| 11
| 1
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 27
| 108
| 10.398438
| 145
| 32
| 38.29688
| 188.5625
| 1.699951
| 7.099609
| 1.199951
| 136
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 3.448242
| 29
| 1
|
76.63495
|
male
| 0
| 25
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
$11-$25k
| 0
| 63,938
| null | null | 14.25
|
white
| 31
| 56
| 0.625
| 0.440979
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 25
| 47
| 14.398438
| 95
| 30
| 37.5
| 184
| null | null | 1.599854
| 134
| 7.459961
| null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 59
| 1
|
51.20099
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 41,580
| 19,861.5625
| null | 29
|
asian
| 30
| 60
| 0.765991
| 0.691895
| 1
| 1
| 0
|
no
| 0.5
| 0.2
|
dnr after sadm
| 6
| 68
| 22.796875
| 110
| 24
| 37.89844
| 212.5
| 1.699951
| 4.299805
| 3.199707
| 133
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 2.691406
| 8
| 1
|
20.24399
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 11,528
| 6,997.7109
| null | 8.5
|
hispanic
| 21.597656
| 25
| 0.938965
| 0.895996
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 9
| 60
| 8.699219
| 70
| 24
| 36
| null | null | null | 1.599854
| 128
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.849121
| 144
| 1
|
69.47296
|
female
| 0
| 36
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
>$50k
| 0
| 151,788
| null | null | 16
|
white
| 30.398438
| 45
| 0.483948
| 0.282959
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 36
| 71
| 10.199219
| 68
| 20
| 36.80469
| null | 2.599609
| 18.597656
| 1.599854
| 126
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,573
| 0
|
76.76099
|
female
| 1
| 8
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 18,406
| 9,426.6562
| null | 14
|
white
| 21.5
| 20
| 0.571899
| 0.250977
| 1
| 1
| 0
|
metastatic
| null | null |
dnr after sadm
| 5
| 67
| 11.398438
| 92
| 20
| 36.39844
| 368
| null | null | 0.599976
| 130
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 3.887207
| 8
| 1
|
24.56699
|
female
| 0
| 66
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 392,270
| null | null | 29.75
|
hispanic
| 28.296875
| 55
| 0.853882
| 0.803955
| 3
| 0
| 0
|
no
| 0.2
| 0.008
|
no dnr
| 66
| 65
| 10.199219
| 130
| 32
| 38.5
| 166.65625
| null | 0.799927
| 8.798828
| 137
| 7.369141
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,571
| 0
|
53.62097
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 28,094
| 14,153.4141
| null | 18
|
white
| 15.699219
| 4
| 0.851929
| 0.672974
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 10
| 80
| 9.699219
| 105
| 22
| 38.19531
| 476.1875
| null | null | null | 140
| 7.40918
| null | null | null | null | null | null | 2.598145
| 1,572
| 0
|
78.88794
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
>$50k
| 44
| 88,377
| 44,241.8438
| null | 26
|
white
| 22
| 37
| 0.379944
| 0.260986
| 5
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 4
| 73
| 7.199219
| 105
| 25
| 38.59375
| 198
| null | null | 1.699951
| 147
| 7.5
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 7
| 1
|
68.40497
|
female
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 32,994
| 16,753.8906
| null | 15.666664
|
white
| 18.296875
| 32
| 0.67395
| 0.375977
| 1
| 0
| 0
|
metastatic
| 0.2
| 0
|
no dnr
| 14
| 62
| 7.899414
| 75
| 30
| 36.59375
| 257.125
| null | null | 1.799805
| 136
| 7.459961
| null | null | null | 0
| null | null | 0.4948
| 330
| 1
|
74.94299
|
male
| 1
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 61
| 345,855
| 174,356.5
| null | 38
|
black
| 21.597656
| 30
| 0.55896
| 0.445984
| 3
| 1
| 0
|
no
| null | null |
dnr after sadm
| 43
| 107
| 22.5
| 105
| 30
| 38.09375
| 300
| null | 1.099854
| 1.099854
| 131
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 3.674316
| 45
| 1
|
72.98798
|
female
| 1
| 4
|
Coma
|
Coma
| 1
| 12
| null | 100
| 16,404
| 8,632.5156
| null | 22
|
asian
| 31.597656
| 58
| 0.025997
| 0.011
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 45
| 28.398438
| 185
| 36
| 38.29688
| 423.3125
| 3.399902
| 0.599976
| 1
| 141
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 3.219727
| 4
| 1
|
50.28897
|
female
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 6,673
| 3,496.5977
| null | 10
|
white
| 13.599609
| 16
| 0.87793
| 0.723999
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 83
| 9.398438
| 84
| 20
| 38
| null | null | 0.599976
| 1.399902
| 136
| null | null | null | null | null | null | null | 1.871582
| 67
| 1
|
87.48297
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 4,969
| 2,898.3867
| null | 5
|
white
| 17.5
| 18
| 0.81897
| 0.705933
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 83
| 13.398438
| 60
| 18
| 36.79688
| null | null | null | 1
| 134
| null | null | null | null | null | null | null | 2.849121
| 636
| 1
|
25.95799
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
>$50k
| 0
| 73,645
| 34,122.2188
| null | 24
|
white
| 52
| 76
| 0.186981
| 0.097992
| 11
| 0
| 0
|
yes
| 0.05
| 0.000125
|
dnr after sadm
| 4
| 123
| 2.199707
| 115
| 32
| 35.29688
| 56
| null | 10.199219
| 1.599854
| 129
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.412598
| 7
| 1
|
78.88794
|
female
| 0
| 48
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 7
| null | 0
| 198,860
| null | null | 22.75
|
white
| 29.5
| 28
| 0.566895
| 0.454956
| 8
| 0
| 0
|
no
| null | null |
no dnr
| 48
| 55
| 19.398438
| 90
| 14
| 38.79688
| 160
| 2.699707
| null | 0.5
| 128
| 7.5
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.538086
| 1,560
| 0
|
52.30099
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 4,510
| 2,831.8672
| null | 9
| null | 4
| 15
| 0.940918
| 0.858887
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 87
| 7.699219
| 62
| 20
| 36.19531
| null | 4.699219
| 0.5
| 1
| 134
| null | null | null | null | null | null | null | 1.562012
| 161
| 1
|
49.08698
|
male
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
| null | 37
| 176,752
| 82,695.1875
| null | 30.333328
|
white
| 51.5
| 106
| 0.030998
| 0.007999
| 18
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 2
| 48
| 37.59375
| 145
| 28
| 38.29688
| 118
| 4.799805
| 19.296875
| 4.699219
| 142
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 3.022461
| 16
| 1
|
54.48599
|
female
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 15
| null | 0
| 37,609
| 18,547.4219
| null | 26.5
|
white
| 23.597656
| 32
| 0.734985
| 0.465942
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.95
|
no dnr
| 11
| 73
| 12.798828
| 120
| 30
| 37
| 388.5625
| 4
| 1
| 1.099854
| 133
| 7.329102
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,558
| 0
|
32.70599
|
female
| 1
| 103
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 21
| null | 55
| 1,233,213
| null | null | 45
|
white
| 34
| 52
| 0.564941
| 0.453979
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 103
| 122
| 7.299805
| 105
| 15
| 36.19531
| 192.5
| 4
| 9.5
| 3.799805
| 149
| 7.449219
| null | null | null | null | 3
| null | 3
| 103
| 1
|
40.46799
|
female
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
>$50k
| 26
| 289,233
| null | null | 36.75
|
white
| 37.195313
| 39
| 0.480957
| 0.362976
| 8
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 46
| 42
| 12.898438
| 125
| 34
| 38.29688
| 155
| 2.899902
| 0.599976
| 0.799927
| 135
| 7.509766
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 265
| 1
|
76.47095
|
male
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 26
| 203,430
| 96,371.6875
| null | 44.666657
|
asian
| 39.898438
| 68
| 0.156982
| 0.076996
| 9
| 1
| 0
|
no
| 0.5
| 0.1
|
dnr after sadm
| 9
| 67
| 14.398438
| 145
| 10
| 39
| 98.32812
| 2.199707
| 15.298828
| 1.5
| 153
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 3.045898
| 24
| 1
|
64.20496
|
female
| 1
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
>$50k
| 55
| 103,876
| 48,555.0938
| null | 30
|
hispanic
| 34.796875
| 60
| 0.141998
| 0.032997
| 1
| 0
| 0
|
no
| 0.2
| 0.75
|
dnr after sadm
| 13
| 52
| 17.597656
| 110
| 38
| 36
| 165
| 2.399902
| 2.699707
| 1.399902
| 135
| 7.459961
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 14
| 1
|
56.07397
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 26
| 131,009
| 60,624
| null | 21.75
|
white
| 45.695313
| 68
| 0.123993
| 0.054993
| 14
| 0
| 0
|
no
| null | null |
no dnr
| 25
| 40
| 8.599609
| 150
| 42
| 36.39844
| 166
| 3.299805
| 5.699219
| 1.5
| 149
| 7.399414
| null | null | null | null | 4
|
SIP>=30
| 4
| 1,552
| 0
|
73.01794
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
$25-$50k
| 0
| 57,560
| 28,266.1094
| null | 16.666656
|
hispanic
| 24.199219
| 17
| 0.775879
| 0.703979
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 21
| 73
| 13.298828
| 65
| 16
| 38.39844
| 390
| null | null | 1
| 120
| 7.439453
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,551
| 0
|
75.50195
|
female
| 0
| 13
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 14,005
| 7,870.8984
| null | 9
|
white
| 15.699219
| 15
| 0.814941
| 0.602905
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 13
| 104
| 12.898438
| 70
| 22
| 36.39844
| null | null | 0.799927
| 1
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,551
| 0
|
66.77594
|
female
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| null | null | 26
| 46,753
| 22,527.5625
| null | 14
|
white
| 5.799805
| 25
| 0.885986
| 0.741943
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 12
| 73
| 15.298828
| 105
| 10
| 38
| 223.3125
| 2.199707
| 0.199982
| 0.699951
| 136
| 7.40918
| null | null | null | null | null | null | 2.353027
| 1,551
| 0
|
52.30698
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 26
| 54,390
| 26,411.8438
| null | 15.5
|
black
| 26.398438
| 42
| 0.696899
| 0.605957
| 5
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 8
| 113
| 14.398438
| 105
| 37
| 38.29688
| 245.6875
| 2.399902
| 6
| 1.299805
| 132
| 7.459961
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,548
| 0
|
50.17099
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 13,399
| 7,692.7422
| null | 12
|
white
| 19.699219
| 15
| 0.688965
| 0.397949
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 84
| null | 108
| 30
| 36.19531
| null | null | null | null | 140
| null | null | null | null | 0
| null | null | 0.4948
| 1,545
| 0
|
47.18997
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 160,900
| 86,296.3125
| null | 43
|
other
| 39.398438
| 68
| 0.546997
| 0.432983
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 60
| 26.097656
| 140
| 39
| 37
| 154.28125
| null | 7.899414
| 2.199707
| 148
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 2.745606
| 7
| 1
|
55.25497
|
female
| 1
| 7
|
Lung Cancer
|
Cancer
| 1
| null | null | 37
| 13,593
| 6,582.4961
| null | 14
|
black
| 20.5
| 25
| 0.491943
| 0.171997
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 4
| 63
| 9.798828
| 120
| 28
| 38
| null | null | 0.899902
| 0.699951
| 142
| null | null | null | null | null | null |
<2 mo. follow-up
| 4.005859
| 7
| 1
|
59.36798
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 15,494
| 7,495.375
| null | 15
|
white
| 22.296875
| 35
| 0.852905
| 0.757935
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 62
| 5.899414
| 145
| 24
| 36.5
| 440
| null | 0.699951
| 1.299805
| 131
| 7.549805
| null | null | null | null | 5
| null | 5
| 1,545
| 0
|
63.22498
|
male
| 0
| 13
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 34,247
| 17,673.3125
| null | 25
| null | 7.299805
| 12
| 0.91394
| 0.799927
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 13
| 87
| 10
| 105
| 22
| 38
| null | 4.399414
| 0.399963
| 1
| 132
| null | null | null | null | null | null | null | 2.176758
| 95
| 1
|
54.69699
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
|
>$50k
| 26
| 168,940
| 85,338.75
| null | 29
|
white
| 49.5
| 67
| 0.003
| 0
| 56
| 0
| 0
|
yes
| 0.05
| 0.000125
|
dnr after sadm
| 4
| 82
| 0.599976
| 115
| 34
| 36.5
| 171.40625
| 4.199219
| 26.699219
| 7.299805
| 151
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.468262
| 4
| 1
|
75.66095
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 16,067
| 8,125.9375
| null | 25
|
white
| 23
| 42
| 0.785889
| 0.656982
| 1
| 0
| 0
|
no
| 0.95
| 0.5
|
no dnr
| 6
| 55
| 9.898438
| 70
| 22
| 36.69531
| null | 3.599609
| 1
| 2.599609
| 135
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.421875
| 1,542
| 0
|
65.09198
|
female
| 0
| 17
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 26
| 56,695
| 29,327
| null | 21
|
white
| 8.398438
| 23
| 0.863892
| 0.696899
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 17
| 120
| 6.799805
| 100
| 28
| 37.5
| 182
| 4.399414
| 0.299988
| 1
| 139
| 7.359375
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 203
| 1
|
60.55298
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 5,619
| 3,247.3672
| null | 10
|
white
| 3.599609
| 11
| 0.894897
| 0.758911
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 83
| 4.5
| 78
| 20
| 36.89844
| null | 4.299805
| 0.299988
| 1.099854
| 139
| null | null | null | null | null | null | null | 1.7854
| 297
| 1
|
30.015
|
male
| 0
| 99
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 55
| 871,855
| null | null | 27.75
|
white
| 35.09375
| 64
| 0.431946
| 0.311951
| 23
| 0
| 0
|
no
| null | null |
no dnr
| 99
| 58
| 11.298828
| 120
| 6
| 38.39844
| 290
| 3.699707
| 16.699219
| 5.399414
| 141
| 7.419922
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 635
| 1
|
35.92899
|
male
| 1
| 20
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 39,582
| 21,738.4375
| null | 7.666664
|
white
| 16.097656
| 26
| 0.872925
| 0.714966
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.05
|
dnr after sadm
| 16
| 85
| 5.099609
| 64
| 10
| 36.19531
| null | 4.099609
| null | 1.799805
| 131
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.546875
| 20
| 1
|
54.84998
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 16
|
$11-$25k
| 26
| 3,278
| 2,616.9863
| null | 4
|
black
| 16.097656
| 13
| 0.656982
| 0.352966
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 100
| 7.899414
| 80
| 18
| 36
| null | null | null | 0.799927
| 136
| null | null | null | null | 3
| 1
|
SIP>=30
| 1
| 95
| 1
|
90.32196
|
female
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 26
| 106,419
| 50,455.5938
| null | 18
|
white
| 20.597656
| 30
| 0.643921
| 0.542969
| 3
| 0
| 1
|
no
| 0.2
| 0.15
|
dnr after sadm
| 7
| 68
| 11.099609
| 45
| 12
| 37
| 237.5
| null | null | 1
| 133
| 7.459961
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 50
| 1
|
84.33899
|
female
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 271,224
| 129,202.75
| null | 23
|
white
| 30.898438
| 50
| 0.312988
| 0.199982
| 45
| 0
| 0
|
no
| 0.3
| 0.1
|
dnr after sadm
| 18
| 110
| 12.798828
| 70
| 16
| 35.89844
| 134.6875
| null | null | 5
| 134
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 3.480469
| 24
| 1
|
57.23999
|
male
| 0
| 50
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 19
|
>$50k
| 44
| 410,745
| 212,786.5
| null | 41
|
white
| 38.5
| 64
| 0.161987
| 0.042
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 50
| 57
| 2.799805
| 110
| 9
| 34
| 257.125
| 3
| 7
| 2.699707
| 150
| 7.459961
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.99707
| 1,525
| 0
|
38.80399
|
female
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 133,255
| 76,584.625
| null | 26.666656
|
white
| 24.296875
| 33
| 0.824951
| 0.715942
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 22
| 60
| 6.899414
| 120
| 16
| 36.09375
| null | 3.399902
| 0.299988
| 2.199707
| 137
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,524
| 0
|
72.46497
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 5,552
| 3,448.8789
| null | 10
|
black
| 17.398438
| 12
| 0.680908
| 0.385986
| 1
| 1
| 0
|
metastatic
| null | null |
no dnr
| 5
| 83
| 13
| 74
| 20
| 36.19531
| null | null | null | 0.799927
| 135
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.616699
| 54
| 1
|
92.60199
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
$25-$50k
| 44
| 50,810
| 24,484.25
| null | 18.333328
|
white
| 23.699219
| 33
| 0.511963
| 0.395996
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 16
| 120
| 22.296875
| 115
| 24
| 36
| 388.5625
| 2.199707
| 0.899902
| 1.599854
| 141
| 7.429688
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 54
| 1
|
59.69299
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 44
| 71,936
| 35,045.9688
| null | 22
|
white
| 36.398438
| 45
| 0.042999
| 0.012999
| 15
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 2
| 73
| 4.299805
| 128
| 8
| 38.39844
| 95
| null | null | 1.699951
| 155
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 3.4375
| 5
| 1
|
52.767
|
male
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
>$50k
| 0
| 43,499
| 20,655.6406
| null | 12.5
|
white
| 21.398438
| 30
| 0.809937
| 0.691895
| 1
| 0
| 0
|
no
| 0.6
| 0.7
|
no dnr
| 12
| 77
| 2.699707
| 64
| 22
| 36.79688
| null | 2.699707
| 5
| 0.899902
| 130
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 217
| 1
|
54.97098
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
>$50k
| 0
| 4,936
| 3,261.3223
| null | 9
|
black
| 15.5
| 15
| 0.930908
| 0.882935
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 5
| 93
| 10.398438
| 88
| 24
| 36.39844
| 272
| null | 0.299988
| 1.099854
| 135
| 7.389648
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,515
| 0
|
62.35699
|
male
| 0
| 26
|
Coma
|
Coma
| 0
| null | null | 44
| 58,097
| 34,727.1562
| null | 10.25
| null | 20.5
| 30
| 0.609985
| 0.546997
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 26
| 130
| 12.199219
| 110
| 30
| 37
| 260
| null | 0.5
| 0.899902
| 146
| 7.579102
| null | null | null | null | null | null | 2.039063
| 1,514
| 0
|
82.01196
|
female
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 11
|
$11-$25k
| 0
| 45,384
| 20,617.7188
| null | 12
|
white
| 28.398438
| 59
| 0.594971
| 0.403992
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 18
| 63
| 19.398438
| 110
| 32
| 36.29688
| 160.6875
| 3.899902
| 0.199982
| 2
| 153
| 7.369141
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 27
| 1
|
53.46997
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 23,440
| 11,864.6953
| null | 8.5
|
white
| 23.796875
| 34
| 0.85498
| 0.759888
| 1
| 0
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 11
| 77
| 11.699219
| 50
| 26
| 36.89844
| 360
| null | 0.399963
| 2.5
| 140
| 7.439453
| null | null | null | 2
| 3
|
no(M2 and SIP pres)
| 3
| 465
| 1
|
21.092
|
male
| 1
| 6
|
Coma
|
Coma
| 0
| 12
|
>$50k
| 89
| 91,295
| 43,409.4062
| null | 36
|
white
| 31.597656
| 51
| 0.370972
| 0.296997
| 16
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 57
| 26.699219
| 130
| 14
| 38.89844
| 463.3125
| null | 12.5
| 1.099854
| 150
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 2.537598
| 6
| 1
|
19.866
|
female
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 11
| null | 0
| 120,028
| 62,699.75
| null | 22.666656
|
black
| 37.195313
| 41
| 0.80188
| 0.679932
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 22
| 47
| 11.599609
| 120
| 28
| 38
| null | 3.199707
| 3.299805
| 0.799927
| 128
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 145
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.